Medline Pops on Nasdaq as IPO Market Flashes Risk-On Signal
Medline’s debut on Nasdaq delivered a clear signal that risk appetite in equity markets remains alive heading into year end. Shares of the medical supplies giant surged on their first day of trading, pushing its valuation to roughly forty six billion dollars and instantly making it the largest IPO of 2025. The strong opening reflected […]